Jill S Rogalskyj

Title: **Inventor Spotlight: Jill S. Rogalskyj**

Introduction

Jill S. Rogalskyj, a prominent inventor based in Livonia, NY, has made significant contributions to the field of ophthalmic innovations. With a total of three patents to her name, her work primarily focuses on the development of advanced solutions for contact lens treatment, enhancing user safety and comfort.

Latest Patents

Rogalskyj's latest patents include:

1. **Treatment of contact lenses with aqueous solution comprising a biguanide** - This invention revolves around an aqueous disinfecting solution that integrates an improved buffer system utilizing both phosphate and borate buffers. The aim is to provide effective methods and compositions for simultaneously cleaning and disinfecting contact lenses.

2. **Dual neutralization system for iodine treatment of contact lenses** - This patent outlines a method for disinfecting contact lenses using iodine, supported by a neutralizing solution that employs a two-component system. The first component reacts rapidly with available iodine in under five seconds, while the second component achieves its reaction over a duration of approximately 3 to 30 minutes.

Career Highlights

Jill Rogalskyj is currently associated with Bausch & Lomb Incorporated, a company well-known for its focus on eye health and wellness products. Her role as an innovator contributes to the company's continued dedication to enhance the safety and efficacy of contact lens care.

Collaborations

Throughout her career, Jill has collaborated with notable professionals in her field, including David J. Heiler and Erning Xia. These collaborations have enriched her research and development efforts, enabling her to create impactful inventions that benefit contact lens users everywhere.

Conclusion

Jill S. Rogalskyj exemplifies the spirit of innovation in the field of contact lens treatment. Her patents signify a commitment to enhancing user experience while employing cutting-edge scientific principles. With her expertise, she continues to play a pivotal role in advancing ophthalmic research and development.